BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 25617150)

  • 1. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(piperazin-1-yl)propan-1-one derivatives.
    Chander S; Wang P; Ashok P; Yang LM; Zheng YT; Murugesan S
    Bioorg Chem; 2016 Aug; 67():75-83. PubMed ID: 27288643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and in-vitro evaluation of novel tetrahydroquinoline carbamates as HIV-1 RT inhibitor and their antifungal activity.
    Chander S; Ashok P; Zheng YT; Wang P; Raja KS; Taneja A; Murugesan S
    Bioorg Chem; 2016 Feb; 64():66-73. PubMed ID: 26717022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
    Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
    Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antibacterial and potential anti-HIV activity of some novel imidazole analogs.
    Ganguly S; Vithlani VV; Kesharwani AK; Kuhu R; Baskar L; Mitramazumder P; Sharon A; Dev A
    Acta Pharm; 2011 Jun; 61(2):187-201. PubMed ID: 21684846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Antimicrobial Evaluation and Docking Study of Novel 3,5-Disubstituted-2-Isoxazoline and 1,3,5-Trisubstituted-2-Pyrazoline Derivatives.
    Ismail AH; Abdula AM; Tomi IHR; Al-Daraji AHR; Baqi Y
    Med Chem; 2021; 17(5):462-473. PubMed ID: 31702515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Synthesis of Molecular Docking Studies, In Vitro Antimicrobial and Antifungal Activities of Novel Dipeptide Derivatives Based on N-(2-(2-Hydrazinyl-2-oxoethylamino)-2-oxoethyl)-nicotinamide.
    Moustafa G; Khalaf H; Naglah A; Al-Wasidi A; Al-Jafshar N; Awad H
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29584635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and anti-HIV-1 RT evaluation of 2-(benzyl(4-chlorophenyl)amino)-1-(piperazin-1-yl)ethanone derivatives.
    Chander S; Wang P; Ashok P; Yang LM; Zheng YT; Sankaranarayanan M
    Bioorg Med Chem Lett; 2017 Jan; 27(1):61-65. PubMed ID: 27894873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines.
    Huang B; Liang X; Li C; Chen W; Liu T; Li X; Sun Y; Fu L; Liu H; De Clercq E; Pannecouque C; Zhan P; Liu X
    Eur J Med Chem; 2015 Mar; 93():330-7. PubMed ID: 25707013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, Antimicrobial and Anti-biofilm Evaluation, and Molecular Docking of Newly Substituted Fluoroquinazolinones.
    Zayed MF; Ibrahim SRM; Habib EE; Hassan MH; Ahmed S; Rateb HS
    Med Chem; 2019; 15(6):659-675. PubMed ID: 30411687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
    Meng Q; Chen X; Kang D; Huang B; Li W; Zhan P; Daelemans D; De Clercq E; Pannecouque C; Liu X
    Eur J Med Chem; 2016 Jun; 115():53-62. PubMed ID: 26994843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase.
    Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R
    Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New azoles with potent antifungal activity: design, synthesis and molecular docking.
    Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W
    Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
    Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
    Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents.
    Wu S; Zhang Y; He X; Che X; Wang S; Liu Y; Jiang Y; Liu N; Dong G; Yao J; Miao Z; Wang Y; Zhang W; Sheng C
    ChemMedChem; 2014 Dec; 9(12):2639-46. PubMed ID: 25196996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Anti-HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding Pocket.
    Chen X; Meng Q; Qiu L; Zhan P; Liu H; De Clercq E; Pannecouque C; Liu X
    Chem Biol Drug Des; 2015 Jul; 86(1):122-8. PubMed ID: 25358434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains.
    Jin K; Sang Y; Han S; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2019 Aug; 176():11-20. PubMed ID: 31091477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
    Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
    Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.